SCHEMBL30639963

SCHEMBL30639963

COC(=O)c1cc(I)c2c(c1N)CCO2

nearest known ligand 0.44

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 3/20 0.44
▸ ALDH1A1 P00352 1/20 0.44
▸ CFTR P13569 1/20 0.42
▸ POLB P06746 1/20 0.39
▸ HTR4 Q13639 3/20 0.38
▸ ACHE P22303 3/20 0.38
▸ HTR1A P08908 1/20 0.38
▸ ADRA2C P18825 1/20 0.38
▸ PTGS1 P23219 1/20 0.38
▸ ADRA1A P35348 1/20 0.38
▸ HTR3A P46098 1/20 0.38
▸ KCNH2 Q12809 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31258473 1.00 KDM4E (0.44) KDM4EALDH1A1CFTRPOLBHTR4
SCHEMBL23698825 0.83 CFTR (0.39) KDM4EALDH1A1CFTRPOLBHTR4
SCHEMBL28947251 0.83 KDM4E (0.44) KDM4EALDH1A1POLBHTR4ACHE
SCHEMBL31115435 0.83 KDM4E (0.44) KDM4EALDH1A1POLBHTR4ACHE
SCHEMBL31417732 0.78 KDM4E (0.44) KDM4EALDH1A1CFTRPOLBHTR4
SCHEMBL5042523 0.78 HTR4 (0.54) KDM4EALDH1A1HTR4ACHEHTR1A
SCHEMBL24104578 0.77 CFTR (0.39) KDM4EALDH1A1CFTRPOLBHTR4
SCHEMBL30077253 0.74 LMNA (0.42) KDM4E
SCHEMBL30077232 0.74 LMNA (0.42) KDM4E
SCHEMBL10320877 0.72 KDM4E (0.48) KDM4EALDH1A1CFTRHTR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115697994-B Fused quinazoline derivative, preparation method thereof and application thereof in medicine 江苏恒瑞医药股份有限公司 2024-08-13 — — CN disclosed
WO-2023185793-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUND, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL APPLICATION THEREOF 江苏恒瑞医药股份有限公司 2023-10-05 — — WO disclosed
Send feedback